Live Analytics
Comments 0
New viral vector vaccine Analytics Table
Income Estimates for New viral vector vaccine
Based on this YouTube video's total view count of 78.2K views and industry-standard rates, the estimated total earning is $55 - $157 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About New viral vector vaccine
Explore New viral vector vaccine with 78,298 views, 6,673 likes, and 1,290 comments. Experience the impact of this video content that has captured audience attention.
For Ebola. New vaccines for Bundibugyo ebolavirus ChAdOx1 Bundibugyo vaccine (Oxford / Serum Institute) Uses the chimpanzee adenovirus (ChAdOx1) platform Similar technology was used in the Oxford AZ COVID-19 vaccine Potentially be ready for early efficacy assessment in 2–3 months How the ChAdOx system works Genes for the antigen are inserted into a viral vector Injection(im) Biodistribution Cell entry Delivers DNA instructions into the cell Antigen production Cell manufactures the viral protein: Both cause human cells to manufacture a viral antigen COVID vaccine → spike protein Ebola vaccine → Ebola glycoprotein For the SARS-CoV-2, spike protein, immunologically important antigen, is believed to be associated with cells surfaces rather than freely circulating.
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

